Weitz & Luxenberg Files Lawsuit Against Bausch & Lomb

Manhattan Law Firm Weitz &
Luxenberg, P.C. announces today that it has filed a lawsuit
against Bausch & Lomb, the makers of the contact lens
solution ReNu with MoistureLoc. Weitz & Luxenberg is
investigating numerous cases and preparing to file more
cases in the following days.

On April 13, 2006, Bausch & Lomb pulled ReNu with
MoistureLoc from suppliers’ shelves over mounting concerns
that the product is being linked to over 100 cases of a rare
fungal eye infection, Fusarium Keratitis, in ReNu with
MoistureLoc users across the country.

In a statement made on April 14, 2006, the FDA supported the
pull of the product from the shelves as the CDC continues to
investigate Bausch & Lomb’s plant in South Carolina where
ReNu with MoistureLoc is manufactured. A similar outbreak
occurred in Asia earlier this year prompting Bausch & Lomb
to pull ReNu with MoistureLoc from shelves there. Singapore,
Malaysia and Hong Kong are also supplied ReNu with
MoistureLoc from Bausch & Lomb’s South Carolina plant.

Furthermore, on May 3, 2006 it was revealed that the CDC has
informed Bausch & Lomb that they are concerned that the
problem may not be isolated to ReNu with MoistureLoc, but
might also affect other Bausch & Lomb products including
ReNu MultiPlus.

Weitz & Luxenberg, which recently obtained a successful
Vioxx verdict against Merck, has filed a lawsuit on behalf
of one of their clients who was diagnosed with Fusarium
Keratitis after using ReNu with MoistureLoc. The Plaintiff,
a resident of suburban Philadelphia, used ReNu with
MoistureLoc and was infected with the suspect fungal
infection. The infection was so grave she required a corneal
transplant. Since then, she has endured months of medical
treatment. This fungus, not only being linked to serious eye
injuries, including corneal damage, can also lead to
blindness.

Because of the serious nature of these injuries, Weitz &
Luxenberg is investigating cases on behalf of people who
have used ReNu with MoistureLoc and have suffered eye
injuries as a consequence.

People injured by ReNu with MoistureLoc should contact Weitz
& Luxenberg by calling Weitz & Luxenberg’s Client Relations
Department at 800-476-6070 or emailing
clientrelationsweitzlux. Please also visit Weitz &
Luxenberg’s website at weitzlux and click on
“Breaking News – ReNu” for more up-to-the-minute
information.

View drug information on Vioxx.